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| INTRODUC TI ON
At the time of initial priming, CD4 + T cells differentiate into various effector subsets, guided by specific antigen-presenting cells and the cytokine mileu. Recent studies have defined that differentiation and subsequent effector functions are accompanied by a switch in the metabolic programming which occurs in a context-specific manner to meet the bioenergetic demands created during infection or inflammation. 1 Deciphering the relative importance of distinct metabolic pathways employed by cells is essential for greater understanding of immune cell biology in order to design future therapeutics. However, delineating the metabolic dependencies of immune cells is complicated by the extensive interdependence between the primary bioenergetic pathways.
In brief, cells derive energy, stored as ATP and NADH, from the oxidation of glucose through glycolysis, mitochondrial oxidative phosphorylation (OxPhos) and the electron transport chain (ETC), to generate CO 2 and water. Glucose is lysed to pyruvate that is converted to acetyl-CoA at the inner mitochondrial membrane. The innate lymphoid cell (ILC) family is defined by the lack of classical lineage markers for T cells, B cells, DCs, or macrophages, are enriched at barrier surfaces, and function primarily through the production of cytokines to modulate immune responses, restore barrier integrity, and maintain tissue homeostasis. 6 ILCs can be considered an innate counterpart to the adaptive CD4 + T-cell lineage, sharing similar transcriptional programs and cytokine effector profiles that allow them to be functionally classified into subsets analo- Further, we also speculate on the biological importance of the conserved vs unique features between ILC and CD4 + T-cell metabolism, drawing focus to the potential clinical implications of these findings.
| TH1 CD 4 + T CELL S , NK CELL S , AND

ILC1S
The activation and differentiation of naïve CD4 + T cells into ef- for histone acetylation and activation of the IFN-γ locus. 13 As a result, mice with a T cell-specific deletion of LDHA were protected from IFN-γ-induced autoimmune pathology. 13 The reliance of Th1 CD4 + T-cell function on glycolysis could also reduce the accumulation of harmful ROS produced via mitochondrial OxPhos. 14 Specifically, RhoA-deficient T cells exhibit a defect in Th2 differentiation and reduced allergic airway inflammation, and this was associated with lower levels of IL-4R, GATA3 and phosphorylated STAT6 levels. 29 Conversely, hyperactivation of RhoA signals, by deletion of a negative regulator Rho GAP, exacerbated OVA-induced airway inflammation. Mechanistically, RhoA was found to critically support glycolysis, as blockade of glycolysis with the glucose analog 2-DG could recapitulate these phenotypes, and supplementing RhoAdeficient Th2 CD4 + T-cell cultures with pyruvate was sufficient to restore IL-13 production. 29 Further, this appears to be selective to In the context of airway inflammation, recent studies have identified two metabolic pathways that affect ILC2 glycolytic function.
Under conditions of hypoxia, one study found that deletion of VHL, a negative regulator of HIF-1α, impaired the maturation of lung ILC2s In a different study under normoxic conditions, deletion of the amino acid catabolic enzyme Arginase 1 (Arg1) impaired ILC2 cytokine production and proliferation, thereby protecting against the development of airway inflammation. 31 Inhibition of Arg1 activity had broad effects on ILC2 metabolism, severely curtailing polyamine synthesis and reducing glycolysis. Whether this impairment in glycolytic capacity is due to insufficient metabolites for protein synthesis or other mechanisms is yet to be determined. 31 Interestingly, Arg1 has also been identified in fetal ILC precursors, 33 but whether this enzyme may instruct metabolic programming during early ILC development and lineage commitment is unknown.
In addition to glycolysis, recent evidence suggests that ILC2s can employ other metabolic pathways to fuel their effector functions.
Research by Wilhelm et al 34 found that among all ILC subsets, ILC2s
exhibited the highest uptake of exogenous fatty acids from the environment, which was further increased in the absence of retinoic acid. While inhibition of FAO did not affect ILC2 development, limiting absorption of FA reduced cytokine production and impaired expulsion of Trichuris muris worms from the intestine. 34 Intriguingly, blocking glycolysis did not impact antihelminth immunity, suggesting a context-dependent distinction between the metabolic pathways engaged by ILC2s during intestinal immunity and those observed in studies of lung inflammation. Furthermore, the metabolic programming of ILC2s is likely to extend well beyond glucose metabolism, as RNA-sequencing analyses of naïve intestinal ILC2s revealed enrichment in transcripts associated with alanine/glutamate metabolism and sphingolipid metabolism. 27 While the biological relevance of these pathways has yet to be explored in ILC2 biology, it suggests that ILC2 metabolic programming is multifaceted. Taken together, these studies illustrate the complexity of ILC2 metabolism and suggests that ILC2 metabolic programming is highly adaptable depending upon the inflammatory stimulus and tissue environment. 40 In addition to glucose, Th17 CD4 + T cells can also utilize glutamine via glutaminolysis as a source of energy. This process is regulated by the transcriptional factor ICER, which controls expression of glutaminase1 (GLS1), an enzyme that converts glutamine to glutamate and then subsequently to aspartate, pyruvate, or α-ketoglutarate. 41 In EAE mouse models, chemically blocking or shRNA-mediated downregulation of GLS1 reduced Th17 CD4 + T-cell responses, T-cell infiltration into the spinal cord, and overall disease severity. Critically, this modulation occurred independent of changes to glycolysis, suggesting that dependency on glutaminolysis is advantageous to Th17 CD4 + T-cell function in tissues with reduced glucose availability. differentiation. 55 Subsequently, mice deficient in HIF-1α are resistant to EAE disease with reduced cellular infiltration into the spinal cord and increased numbers of Tregs in the central nervous system and peripheral immune organs. 54, 55 A major regulator of HIF-1α expression is mTOR, which acts as a balancing point between Th17 CD4 + T cell and Treg differentiation. mTOR regulates the expression of proteins not just in the glycolytic pathway but also in PPP, FAO, and mitochondrial biogenesis. Th17 CD4 + T-cell differentiation is impaired by mTORC1 blockade, while blocking mTORC2 does not. 19 The impact of mTOR activity on T-cell differentiation has been comprehensively reviewed. 18, 56 Despite these advances on understanding the bioenergetics pathways employed by Th17 CD4 + T cells, the metabolic dependencies of ILC3 are still largely unexplored (Figure 3 ). ILC3s resemble Th17 CD4 + T cells in transcription factor and effector cytokine expression, yet exhibit substantially more cellular heterogeneity and functionality. RNA-sequencing analyses of intestinal ILC3 in naïve mice revealed enrichment of transcripts associated with glycolysis (Hk2, Hk3, enolase-1, and phosphofructokinase), as well as metabolism of fructose/mannose, galactose, and pyruvate. 27 Currently, one study demonstrates that ILC3s in the intestine uptake FAs from the environment, but the significance of this phenomenon is yet to be determined. 34 inhibited IL-22 production from ILC3s, through an unknown mechanism. 59 Substantial additional investigation is needed to determine which primary and context-dependent bioenergetics pathways are employed by ILC3s during development, homeostasis, and function.
| TH17 CD + T CELL S AND ILC 3S
| REG UL ATORY T CELL S
As stated earlier, freshly isolated human Tregs have high glycolytic potential due to elevated mTORC1 activity, low phosphorylated AMPK levels and are hyporesponsive to TCR stimuli. This anergic state is maintained by the mTOR-dependent leptin production, which constrains Treg function. 37, 60 In activated murine Tregs, FoxP3 induces the shift to OxPhos while blocking glycolysis (by suppressing Myc) and favoring the oxidation of lactate to pyruvate. The impact of cellular metabolism in ILC3s has yet to be com- Award.
